| Block buster cancer drug Avastin gives hope to brain tumor victims
In a phase II clinical trial Avastin extended the survival rate of patients with glioblastoma multiforme (GBM). Glioblastoma multiforme is the most common and aggressive type of primary brain tumor, and accounts for 52% of all primary brain tumor cases and 20% of all intracranial tumors. Despite being the most prevalent form of primary brain tumor, GBM's occur at only 2-3 cases per 100,000 people in Europe and North America. Treatment usually involves chemotherapy, radiotherapy and surgery, all of which are palliative measures and do not provide a cure. Dr. Timothy Cloughesy, who was the lead investigator for the study, says research has shown that only 15 percent of patients with this aggressive type of brain cancer live without their cancer progressing within six months.
One Woman's World
We can ignore the way the wind blows and the way our neighbor parts his hair. We can hide our heads in the sands of illusion and pretend our president has an IQ higher than a truckload of cabbages, and we can even ignore the flu bug, the clogged sinuses and arteries, and a migraine that would make a saint curse ... but we cannot, for very long, ignore diabetes. I tried for two years to deny the very word, to ignore all the signs, and I strutted around proclaiming "The mind is more powerful than the body." I ate what I pleased, when I pleased, and declared to an invisible, nonexistent "them" that "You all can't tell me what to eat." Diagnosed two years ago as "diabetes type 2" by a doctor I met for the first time while visiting on the West Coast two summers ago, I decided the good doctor was, no doubt, wrong and I sailed merrily along for about a year and a half.
EDITOR'S CHOICE
It is strange how it turns out because I will be facing John Ward now on Saturday, who I played under at Cheltenham. "He was great to me while I was there, but I would certainly love to score against Carlisle if I get the chance. It is a massive game for us and I'm sure I will celebrate this time if I score." And it is not just because he wants to get one over his former boss that Melligan wants to add to the three goals he has netted for O's. He added: "I suppose some people will look at three goals from midfield at this stage of the season as a good return, but I certainly don't "I feel that I should have had seven or eight by now, because some good chances have come my way. "Hopefully, though, I can make up for that and go on a little run now, because if we are going to have a real push for promotion it is important that everyone chips in with the goals and not just the strikers." 10:35am today Print Email this .
Existing Drugs Show Promise For Treating End-stage Renal Disease In ...
ScienceDaily (Nov. 28, 2007) Studies in mice suggest that two drugs already approved by the U.S. Food and Drug Administration show promise for treating the complications of lupus, according to Nilamadham Mishra, M.D., in presentations this week at the American College of Rheumatology in Boston. .
Cancer patients and doctors in the fog about 'chemobrain'
Jane Blakeman keeps forgetting things.One time, the 50-year-old Bethlehem resident hung up the phone and couldn't recall who was on the other end. Another time, she was standing in the grocery store and didn't know why she was even there. Such extreme moments of memory loss have become rare since Blakeman stopped chemotherapy a year and a half ago. But at the height of what Blakeman referred to as "chemobrain" or "chemofog," she did the unthinkable. She forgot to pick up her daughter after school."She called and said, 'Are you going to pick me up at school?'," Blakeman said. "And I said, 'Sure, what time?' I had no memory of talking to her that morning and agreeing that I would pick her up. As a mother, I was devastated."Only one thing scares Blakeman more than the episode with her daughter: "What else did I forget?"Blakeman was diagnosed with breast cancer two years ago.
|
